Atlas Venture Fund XI, L.P.

Related Filers (18)

Other (2)

144
Thursday, 2/15/2024
Filing for proposed sale of securities under Rule 144
D
Friday, 6/30/2017
Exempt (Private) Offering
Show More

Ownership (38)

4
Friday, 2/9/2024
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/9/2024
Day One Biopharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Friday, 2/9/2024
Dyne Therapeutics, Inc.: Major Shareholders
4
Tuesday, 1/16/2024
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 11/13/2023
Korro Bio, Inc.: Major Shareholders
3
Tuesday, 11/7/2023
Korro Bio, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Day One Biopharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Dyne Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Akero Therapeutics, Inc.: Major Shareholders
4
Wednesday, 12/14/2022
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/14/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 9/29/2022
Third Harmonic Bio, Inc.: Major Shareholders
4
Wednesday, 9/21/2022
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/19/2022
Third Harmonic Bio, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/14/2022
Third Harmonic Bio, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/22/2022
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/11/2022
Dyne Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 2/11/2022
Day One Biopharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Akero Therapeutics, Inc.: Major Shareholders
4
Tuesday, 12/14/2021
Ikena Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/29/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 11/5/2021
Xilio Therapeutics, Inc.: Major Shareholders
4
Tuesday, 10/26/2021
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/21/2021
Xilio Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/15/2021
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Day One Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/26/2021
Day One Biopharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/1/2021
Ikena Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/25/2021
Ikena Oncology, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Tuesday, 2/16/2021
Dyne Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Akero Therapeutics, Inc.: Major Shareholders
4
Wednesday, 9/23/2020
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/16/2020
Dyne Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Thursday, 2/13/2020
Akero Therapeutics, Inc.: Major Shareholders
4
Thursday, 1/2/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/19/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/25/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/19/2019
Akero Therapeutics, Inc.: Initial statement of beneficial ownership of securities
Show More